Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy

被引:19
作者
Zegkos, Thomas [1 ]
Tziomalos, Georgios [1 ]
Parcharidou, Despoina [1 ]
Ntelios, Dimitris [1 ]
Papanastasiou, Christos A. [1 ]
Karagiannidis, Efstratios [1 ]
Gossios, Thomas [1 ]
Rouskas, Pavlos [1 ]
Katranas, Sotiris [1 ]
Paraskevaidis, Stilianos [1 ]
Karvounis, Haralambos [1 ]
Efthimiadis, Georgios [1 ]
机构
[1] Ahepa Univ Hosp, Cardiol Dept 1, Clin Cardiomyopathies & Inherited Cardiac Dis, Thessaloniki, Greece
关键词
hypertrophic cardiomyopathy; sudden death; primary prevention; implantable cardioverter defibrillator; risk stratification; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; VENTRICULAR APICAL ANEURYSM; 2014; EUROPEAN-SOCIETY; PREDICTION MODEL; TASK-FORCE; PREVENTION; DIAGNOSIS;
D O I
10.1016/j.hjc.2021.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of our study was to assess the performance of the new American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines, with respect to sudden cardiac death (SCD) prevention, in comparison with the established risk score of the European Society of Cardiology (hypertrophic cardiomyopathy [HCM] Risk-SCD), in a large Mediterranean cohort of HCM patients. Methods: The clinical and imaging characteristics of 784 HCM patients (mean age at first evaluation 52 +/- 16 years, 67.2% males) were analyzed retrospectively. The sensitivity, specificity, and negative predictive value for SCD events of the presence of >1 risk factor for SCD according to the ACC/AHA Guidelines 2020 and of the HCM Risk-SCD>6% and HCM Risk-SCD>4% were estimated during follow-up. Results: During follow-up, 47 (6%) patients suffered an SCD event. The presence of >1 major risk factor for SCD according to the new ACC/AHA Guidelines had 96% sensitivity (95% CI 85.5-99.5%) with modest specificity of 59% (95% CI 55-62.2%) and negative predictive value of 99.5% (95% CI 98.2-99.9%). On the contrary, HCM-Risk-SCD>6% had a relatively low sensitivity (32%, 95% CI 19.1-47.1%) and high specificity of 95% (95% CI 93.1-96.4%), whereas, HCM-Risk-SCD>4% had sensitivity of 60% (95% CI 44-74%) and specificity of 83.9% (95% CI 80-85.6%). Both the HCM Risk-SCD cut-off values demonstrated lower negative predictive value but higher accuracy than the ACC/AHA algorithm for SCD prediction. Conclusion: The novel ACC/AHA proposed algorithm identifies most of the patients with an SCD event with the cost of numerous defibrillator implantations. HCM-Risk-SCD demonstrated higher specificity, whereas its sensitivity and negative predictive value are modest. (c) 2021 Hellenic Society of Cardiology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:15 / 21
页数:7
相关论文
共 25 条
[1]   Perspectives on Sudden Death Prevention in Hypertrophic Cardiomyopathy [J].
Efthimiadis, Georgios K. ;
Zegkos, Thomas ;
Meditskou, Soultana ;
Hadjimiltiades, Stavros .
CARDIOLOGY IN REVIEW, 2014, 22 (05) :210-216
[2]   Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives [J].
Efthimiadis, Georgios K. ;
Pagourelias, Efstathios D. ;
Gossios, Thomas ;
Zegkos, Thomas .
WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (02) :26-37
[3]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[4]   2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
Gersh, Bernard J. ;
Maron, Barry J. ;
Bonow, Robert O. ;
Dearani, Joseph A. ;
Fifer, Michael A. ;
Link, Mark S. ;
Naidu, Srihari S. ;
Nishimura, Rick A. ;
Ommen, Steve R. ;
Rakowski, Harry ;
Seidman, Christine E. ;
Towbin, Jeffrey A. ;
Udelson, James E. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) :E212-E260
[5]   Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J].
Lang, Roberto M. ;
Badano, Luigi P. ;
Mor-Avi, Victor ;
Afilalo, Jonathan ;
Armstrong, Anderson ;
Ernande, Laura ;
Flachskampf, Frank A. ;
Foster, Elyse ;
Goldstein, Steven A. ;
Kuznetsova, Tatiana ;
Lancellotti, Patrizio ;
Muraru, Denisa ;
Picard, Michael H. ;
Rietzschel, Ernst R. ;
Rudski, Lawrence ;
Spencer, Kirk T. ;
Tsang, Wendy ;
Voigt, Jens-Uwe .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2015, 28 (01) :1-U170
[6]   Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy [J].
Leong, Kevin M. W. ;
Chow, Ji-Jian ;
Ng, Fu Siong ;
Falaschetti, Emanuela ;
Qureshi, Norman ;
Koa-Wing, Michael ;
Linton, Nicholas W. F. ;
Whinnett, Zachary I. ;
Lefroy, David C. ;
Davies, D. Wyn ;
Lim, Phang Boon ;
Peters, Nicholas S. ;
Kanagaratnam, Prapa ;
Varnava, Amanda M. .
AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (03) :349-355
[7]   Hypertrophic cardiomyopathy [J].
Maron, Barry J. ;
Maron, Martin S. .
LANCET, 2013, 381 (9862) :242-255
[8]   Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy [J].
Maron, Barry J. .
CIRCULATION, 2010, 121 (03) :445-456
[9]   Sudden Deaths in Young Competitive Athletes Analysis of 1866 Deaths in the United States, 1980-2006 [J].
Maron, Barry J. ;
Doerer, Joseph J. ;
Haas, Tammy S. ;
Tierney, David M. ;
Mueller, Frederick O. .
CIRCULATION, 2009, 119 (08) :1085-1092
[10]   Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. [J].
Maron, BJ ;
Shen, WK ;
Link, MS ;
Epstein, AE ;
Almquist, AK ;
Daubert, JP ;
Bardy, GH ;
Favale, S ;
Rea, RF ;
Boriani, G ;
Estes, NAM ;
Spirito, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :365-373